BCL2 and melanoma: In the group of melanoma patients studied, although the phenotype of the infiltrating lymphocytes was not determined, a high number of infiltrating L-BCL2+ and levels of IL-4 > 48.5 pg·mL−1 are associated with metastatic progression (86.82% accuracy), suggesting that an immunosuppressive response is being induced in melanoma cells.